| A TTO-derived value set of the EQ-5D-5L for Canada JJACEQDLVSG Xie F, Pullenayegum EM, Gaebel K, Bansback N, Bryan S, Ohinmaa A ... Medical Care, 54 (1), 98, 2016 | 388* | 2016 |
| United States valuation of EQ-5D-5L health states using an international protocol AS Pickard, EH Law, R Jiang, E Pullenayegum, JW Shaw, F Xie, M Oppe, ... Value in health 22 (8), 931-941, 2019 | 281 | 2019 |
| Effect of patient-centered transitional care services on clinical outcomes in patients hospitalized for heart failure: the PACT-HF randomized clinical trial HGC Van Spall, SF Lee, F Xie, UE Oz, R Perez, PR Mitoff, M Maingi, ... Jama 321 (8), 753-761, 2019 | 257 | 2019 |
| Instrument-defined estimates of the minimally important difference for EQ-5D-5L index scores NS McClure, F Al Sayah, F Xie, N Luo, JA Johnson Value in Health 20 (4), 644-650, 2017 | 253 | 2017 |
| Economic and humanistic burden of osteoarthritis: a systematic review of large sample studies F Xie, B Kovic, X Jin, X He, M Wang, C Silvestre Pharmacoeconomics 34, 1087-1100, 2016 | 230 | 2016 |
| A human type 5 adenovirus–based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity F Smaill, M Jeyanathan, M Smieja, MF Medina, N Thanthrige-Don, ... Science translational medicine 5 (205), 205ra134-205ra134, 2013 | 228 | 2013 |
| GRADE guidelines: 20. Assessing the certainty of evidence in the importance of outcomes or values and preferences—inconsistency, imprecision, and other domains Y Zhang, PA Coello, GH Guyatt, JJ Yepes-Nuñez, EA Akl, G Hazlewood, ... Journal of clinical epidemiology 111, 83-93, 2019 | 211 | 2019 |
| Improving the interpretation of quality of life evidence in meta-analyses: the application of minimal important difference units BC Johnston, K Thorlund, HJ Schünemann, F Xie, MH Murad, VM Montori, ... Health and quality of life outcomes 8, 1-5, 2010 | 175 | 2010 |
| Analysis of health utility data when some subjects attain the upper bound of 1: are Tobit and CLAD models appropriate? EM Pullenayegum, JE Tarride, F Xie, R Goeree, HC Gerstein, D O'Reilly Value in Health 13 (4), 487-494, 2010 | 169 | 2010 |
| Validation of Chinese Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) in patients scheduled for total knee replacement F Xie, SC Li, R Goeree, JE Tarride, D O’Reilly, NN Lo, SJ Yeo, KY Yang, ... Quality of Life Research 17, 595-601, 2008 | 145 | 2008 |
| Be healthy in pregnancy: exploring factors that impact pregnant women's nutrition and exercise behaviours LN Grenier, SA Atkinson, MF Mottola, O Wahoush, L Thabane, F Xie, ... Maternal & child nutrition 17 (1), e13068, 2021 | 139 | 2021 |
| Evaluating progression-free survival as a surrogate outcome for health-related quality of life in oncology: a systematic review and quantitative analysis B Kovic, X Jin, SA Kennedy, M Hylands, M Pędziwiatr, A Kuriyama, ... JAMA internal medicine 178 (12), 1586-1596, 2018 | 139 | 2018 |
| Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application R Goeree, J He, D O’Reilly, JE Tarride, F Xie, M Lim, N Burke ClinicoEconomics and Outcomes Research, 89-104, 2011 | 136 | 2011 |
| Cross-cultural adaptation and validation of Singapore English and Chinese versions of the Knee injury and Osteoarthritis Outcome Score (KOOS) in Asians with knee osteoarthritis … F Xie, SC Li, EM Roos, KY Fong, NN Lo, SJ Yeo, KY Yang, W Yeo, ... Osteoarthritis and cartilage 14 (11), 1098-1103, 2006 | 131 | 2006 |
| The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women R Hopkins, R Goeree, E Pullenayegum, J Adachi, A Papaioannou, F Xie, ... BMC musculoskeletal disorders 12 (1), 209, 2011 | 130 | 2011 |
| GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence—An overview in the context of health decision-making JL Brozek, C Canelo-Aybar, EA Akl, JM Bowen, J Bucher, WA Chiu, ... Journal of clinical epidemiology 129, 138-150, 2021 | 120 | 2021 |
| Comparing EQ-5D valuation studies: a systematic review and methodological reporting checklist F Xie, K Gaebel, K Perampaladas, B Doble, E Pullenayegum Medical Decision Making 34 (1), 8-20, 2014 | 112 | 2014 |
| Pangenotypic direct acting antivirals for the treatment of chronic hepatitis C virus infection: a systematic literature review and meta-analysis MJ Zoratti, A Siddiqua, RE Morassut, D Zeraatkar, R Chou, J van Holten, ... EClinicalMedicine 18, 2020 | 110 | 2020 |
| Discussing study limitations in reports of biomedical studies-the need for more transparency MA Puhan, EA Akl, D Bryant, F Xie, G Apolone, G Riet Health and quality of life outcomes 10, 1-4, 2012 | 110 | 2012 |
| The European organization for research and treatment of cancer quality of life questionnaire (EORTC QLQ-C30): validation of English version in Singapore N Luo, CSL Fones, SE Lim, F Xie, J Thumboo, SC Li Quality of Life Research 14, 1181-1186, 2005 | 103 | 2005 |
Lehana ThabaneProfessor and Associate Chair, Health Research Methods, Evidence, and Impact, McMaster Universitymcmaster.ca üzerinde doğrulanmış e-posta adresine sahip